000045090 000__ 00916cam\a22003375i\4500
000045090 001__ 45090
000045090 003__ SzGeWIPO
000045090 005__ 20240708150058.0
000045090 006__ m\\\\eo\\d\\\\\\\\
000045090 007__ cr bn |||m|||a
000045090 008__ 220304s2021\\\\enk\\\\\o\\\\\000\0\eng\d
000045090 0247_ $$a10.1093/jiplp/jpab132$$2doi
000045090 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000045090 041__ $$aeng
000045090 24500 $$aA critical history of the pharmaceutical industry, but not all criticism seems justified.
000045090 264_1 $$a[Oxford, England] :$$bOxford University Press (OUP),$$c2021
000045090 300__ $$a1 online resource (pages 1283-1285)
000045090 337__ $$acomputer$$2rdamedia
000045090 4901_ $$aJournal Of Intellectual Property Law & Practice,$$x1747-1540 ;$$v16, 11, 2021
000045090 542__ $$fhttps://academic.oup.com/jiplp/article-abstract/16/11/1283/6457530
000045090 588__ $$aCrossref
000045090 590__ $$aPublished online: 29-Dec-21
000045090 650_0 $$aIntellectual property.
000045090 650_0 $$aPharmaceutical Industry.
000045090 7001_ $$aSmyth, Darren,$$eauthor.
000045090 7731_ $$tJournal of Intellectual Property Law & Practice$$wjiplp
000045090 830_0 $$aJournal Of Intellectual Property Law & Practice ;$$v16, 11, 2021.
000045090 85641 $$uhttps://doi.org/10.1093/jiplp/jpab132$$yOnline version
000045090 904__ $$aJournal article
000045090 980__ $$aJIPLP